Rankings
▼
Calendar
IMUX
Immunic, Inc.
Mkt Cap
$135M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$97M
EPS (TTM)
-$0.62
Free Cash Flow (TTM)
-$86M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$27M
Q2 23
$0
$0
-$25M
Q3 23
$0
$0
-$24M
Q4 23
$0
-$23K
-$23M
Q1 24
$0
-$26K
-$24M
Q2 24
$0
-$31K
-$23M
Q3 24
$0
$0
-$26M
Q4 24
$0
-$35K
-$26M
Q1 25
$0
$0
-$27M
Q2 25
$0
$0
-$27M
Q3 25
$0
$0
-$26M
Q4 25
$0
-$42K
-$23M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$20M
-$20M
Q2 23
-$20M
-$20M
Q3 23
-$17M
-$17M
Q4 23
-$14M
-$14M
Q1 24
-$24M
-$24M
Q2 24
-$17M
-$17M
Q3 24
-$21M
-$21M
Q4 24
-$23M
-$23M
Q1 25
-$22M
-$22M
Q2 25
-$25M
-$25M
Q3 25
-$20M
-$20M
Q4 25
-$19M
-$19M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$104K
Q2 23
$21K
Q3 23
$44K
Q4 23
$165K
Q1 24
$31K
Q2 24
$180K
Q3 24
$50K
Q4 24
$3K
Q1 25
$47K
Q2 25
$36K
Q3 25
$67K
Q4 25
$11K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+27.1%
Q2 23
—
+21.4%
Q3 23
—
+17.2%
Q4 23
—
-59.2%
Q1 24
—
-12.4%
Q2 24
—
-8.8%
Q3 24
—
+9.1%
Q4 24
—
+9.6%
Q1 25
—
+12.3%
Q2 25
—
+18.7%
Q3 25
—
+1.0%
Q4 25
—
-9.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$2M
—
Q2 23
$2M
—
Q3 23
$2M
—
Q4 23
$2M
—
Q1 24
$3M
—
Q2 24
$2M
—
Q3 24
$2M
—
Q4 24
$2M
—
Q1 25
$2M
—
Q2 25
$2M
—
Q3 25
$4M
—
Q4 25
$1M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$23M
$4M
—
Q2 23
$21M
$4M
—
Q3 23
$20M
$4M
—
Q4 23
$19M
$4M
—
Q1 24
$19M
$5M
—
Q2 24
$18M
$4M
—
Q3 24
$21M
$4M
—
Q4 24
$22M
—
$4M
Q1 25
$22M
$5M
—
Q2 25
$21M
$6M
—
Q3 25
$20M
—
$6M
Q4 25
$19M
$10M
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$93M
$4M
$97M
Q2 23
$77M
$0
$77M
Q3 23
$60M
$0
$60M
Q4 23
$47M
$0
$47M
Q1 24
$97M
$0
$97M
Q2 24
$80M
$0
$80M
Q3 24
$59M
$0
$59M
Q4 24
$36M
$0
$36M
Q1 25
$14M
$0
$14M
Q2 25
$55M
$0
$55M
Q3 25
$35M
$0
$35M
Q4 25
$15M
$0
$15M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
44M
+37.2%
Q2 23
44M
+1.8%
Q3 23
45M
+0.3%
Q4 23
45M
+0.1%
Q1 24
97M
+118.0%
Q2 24
101M
+4.1%
Q3 24
101M
+0.0%
Q4 24
90M
-11.0%
Q1 25
101M
+12.4%
Q2 25
132M
+30.4%
Q3 25
194M
+46.7%
Q4 25
1.56B
+702.9%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$0
96
FY 15
$0
78
FY 16
$73
87
FY 17
$0
97
FY 18
$0
10
FY 19
$0
26
FY 20
$0
28
FY 21
$0
55
FY 22
$0
66
FY 23
$0
77
FY 24
$0
91
FY 25
$0
92
marketcaparena.com
IMUX (Immunic, Inc.) Stock Financials & Earnings | Market Cap Arena